So now that GvHD hasn't been approved surely that will have a negative consequence on OCC?
It's hard to know what has been going on behind the scenes in MSB and their ongoing communication with FDA over the past few years, however I do believe that big US pharma's have a massive influence on FDA approvals and it is very hard for small overseas standalone companies such as OCC and PAR to get approvals without a JV partner.
So now that GvHD hasn't been approved surely that will have a...
-
- There are more pages in this discussion • 261 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.45M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.5¢ | $186.3K | 503.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13513 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 30553 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |